← Open Payments lookup

CHERISSE PERU: Open Payments

NPI 1417598020 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$666 in 29 payments from 13 companies in 2025. Trend: 2023 $455 · 2024 $784 · 2025 $666

Food & beverage: $666
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.4$135
Novartis Pharmaceuticals Corporation4$115
Travere Therapeutics, Inc.5$106
Amgen Inc.4$73
Novo Nordisk Inc2$56
Mallinckrodt Hospital Products Inc.2$52
Lilly USA, LLC2$29
Alnylam Pharmaceuticals Inc.1$19
Ardelyx, Inc.1$18
AKEBIA THERAPEUTICS INC1$17

Products named: TARPEYO, Fabhalta, Vanrafia, TAVNEOS, TERLIVAZ, Rybelsus, JARDIANCE, Ozempic.

Industry payments across MI — which companies pay providers there.